Molecular Framework of T-DXd Acquired Resistance in HER2-Positive Breast Cancer
T-DXd has transformed the world of directed treatment of HER2 positive breast cancer but its clinical benefit over an extended period of time is severely constrained by unavoidable acquired resistance. Although recent studies have examined specific resistance pathways, a comprehensive overview of this very heterogeneou...